Gao et al., 2022 - Google Patents
Complexation with aromatic carboxylic acids expands the solid-state landscape of berberineGao et al., 2022
- Document ID
- 16192954674333882744
- Author
- Gao Z
- Liu S
- Sun C
- Publication year
- Publication venue
- International journal of pharmaceutics
External Links
Snippet
Two novel salt cocrystals of berberine chloride (BCl) with 4-aminobenzoic acid (BCl-4ABA) and 4-hydroxybenzoic acid (BCl-4HBA) and one new berberine salt with 2, 6- dihydroxybenzoic acid (B)+(26DHBA)− were prepared and characterized. The chloride …
- 229940093265 Berberine 0 title abstract description 51
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with heteroatoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gao et al. | Complexation with aromatic carboxylic acids expands the solid-state landscape of berberine | |
| JP6010154B2 (en) | L-ornithine phenylacetate and process for producing the same | |
| ES2676319T3 (en) | Pteroestilbeno co-crystals | |
| Khatioda et al. | Solubility and in vitro drug permeation behavior of ethenzamide cocrystals regulated in physiological pH environments | |
| JP2016517410A (en) | Solid form of treprostinil | |
| CN102746258A (en) | Crystal forms of cabazitaxel and preparation method thereof | |
| Zhu et al. | Stable cocrystals and salts of the antineoplastic drug apatinib with improved solubility in aqueous solution | |
| CN108558861B (en) | Berberine hydrochloride eutectic crystal, preparation method and application thereof | |
| Chen et al. | Sinomenine-phenolic acid coamorphous drug systems: Solubilization, sustained release, and improved physical stability | |
| Wang et al. | Simultaneous improvement of physical stability, dissolution, bioavailability, and antithrombus efficacy of Aspirin and Ligustrazine through cocrystallization | |
| Wang et al. | Crystal structure, dissolution and hygroscopicity of a novel cocrystal hydrate of berberine hydrochloride with L (+)-lactic acid | |
| WO2015170345A1 (en) | Pharmaceutical cocrystals of gefitinib | |
| Rai et al. | Salts, solvates and hydrates of the multi-kinase inhibitor drug pazopanib with hydroxybenzoic acids | |
| Xia et al. | Rucaparib cocrystal: Improved solubility and bioavailability over camsylate | |
| Watanabe et al. | Reduced deliquescency of isosorbide by cocrystallization and mechanisms for hygroscopicity | |
| Zhang et al. | Tetrahydroberberine pharmaceutical salts/cocrystals with dicarboxylic acids: charge-assisted hydrogen bond recognitions and solubility regulation | |
| CN108570046A (en) | A kind of berberine-Chrysin pharmaceutical co-crystals and preparation method thereof | |
| ES2738638T3 (en) | Cabozantinib salts and their use as anticancer agents | |
| Yu et al. | Investigation into the structures and physicochemical properties of multi-component crystals of voriconazole | |
| US10953016B2 (en) | Solid dosage form containing quinazoline derivative | |
| de Oliveira Junior et al. | A new crystalline ketoprofen sodium salt: Solid-state characterization, solubility, and stability | |
| Zou et al. | Gefitinib salts/cocrystals with phenolic acids as a promising solid-state approach to improve solubility | |
| Nechipadappu et al. | New drug–drug and drug–nutraceutical salts of anti-emetic drug domperidone: structural and physicochemical aspects of new salts | |
| Yu et al. | Salt or/and cocrystal? The case of the antidepressant drug venlafaxine | |
| CA2812921A1 (en) | Picropodophyllin polymorphs b or c for use in cancer therapy |